Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China
· Delayed Price · Currency is CNY 57.60
+0.97 (1.71%)
Apr 29, 2026, 3:04 PM CST
SHE:300841 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 7,485 | 9,390 | 6,992 | 10,371 | 11,318 | 19,145 | Upgrade
|
| Market Cap Growth | -6.14% | 34.30% | -32.58% | -8.37% | -40.88% | -31.86% | Upgrade
|
| Enterprise Value | 6,460 | 8,597 | 6,446 | 9,762 | 10,870 | 18,215 | Upgrade
|
| Last Close Price | 57.60 | 72.26 | 53.48 | 73.76 | 80.02 | 132.49 | Upgrade
|
| PE Ratio | 41.16 | 42.70 | 17.54 | 20.37 | 18.92 | 23.08 | Upgrade
|
| Forward PE | - | 20.24 | 9.79 | 15.93 | 8.63 | 25.46 | Upgrade
|
| PS Ratio | 6.42 | 8.06 | 4.88 | 6.58 | 7.82 | 14.81 | Upgrade
|
| PB Ratio | 2.12 | 2.65 | 2.03 | 2.95 | 3.68 | 7.17 | Upgrade
|
| P/TBV Ratio | 2.13 | 2.67 | 2.04 | 2.96 | 3.70 | 7.22 | Upgrade
|
| P/FCF Ratio | 24.23 | 30.40 | 16.34 | 24.89 | - | - | Upgrade
|
| P/OCF Ratio | 19.71 | 24.73 | 12.22 | 18.07 | 58.04 | 146.90 | Upgrade
|
| EV/Sales Ratio | 5.33 | 7.38 | 4.50 | 6.19 | 7.51 | 14.09 | Upgrade
|
| EV/EBITDA Ratio | 18.04 | 24.57 | 10.83 | 14.99 | 16.90 | 28.96 | Upgrade
|
| EV/EBIT Ratio | 22.64 | 31.48 | 12.12 | 16.26 | 17.77 | 29.67 | Upgrade
|
| EV/FCF Ratio | 20.91 | 27.83 | 15.06 | 23.43 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.04 | 0.05 | 0.05 | 0.04 | 0 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.40 | 0.31 | 0.29 | 0.20 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 0.08 | 0.45 | 0.44 | 0.46 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.29 | -0.24 | -0.24 | -0.17 | -0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.85 | -2.89 | -1.37 | -1.30 | -0.82 | -1.47 | Upgrade
|
| Net Debt / FCF Ratio | -2.85 | -3.27 | -1.90 | -2.04 | 2.34 | 5.02 | Upgrade
|
| Asset Turnover | 0.31 | 0.29 | 0.35 | 0.40 | 0.43 | 0.50 | Upgrade
|
| Inventory Turnover | 0.59 | 0.58 | 0.48 | 0.64 | 0.79 | 1.10 | Upgrade
|
| Quick Ratio | 7.36 | 5.41 | 4.06 | 3.62 | 3.20 | 5.21 | Upgrade
|
| Current Ratio | 7.89 | 5.74 | 4.39 | 3.90 | 3.51 | 5.73 | Upgrade
|
| Return on Equity (ROE) | 6.44% | 6.30% | 11.45% | 15.46% | 20.82% | 35.72% | Upgrade
|
| Return on Assets (ROA) | 4.49% | 4.25% | 8.07% | 9.48% | 11.37% | 14.86% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.30% | 8.96% | 17.13% | 20.43% | 24.92% | 46.86% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.80% | 7.60% | 15.40% | 17.00% | 19.70% | 22.90% | Upgrade
|
| Earnings Yield | 2.94% | 2.34% | 5.70% | 4.91% | 5.28% | 4.33% | Upgrade
|
| FCF Yield | 4.13% | 3.29% | 6.12% | 4.02% | -1.98% | -0.96% | Upgrade
|
| Dividend Yield | 1.77% | - | 1.87% | 2.71% | 0.63% | 0.76% | Upgrade
|
| Payout Ratio | 62.04% | 62.04% | 67.18% | 14.07% | 22.88% | 10.85% | Upgrade
|
| Buyback Yield / Dilution | 0.64% | 1.30% | 1.56% | 0.17% | 0.46% | -13.94% | Upgrade
|
| Total Shareholder Return | 2.38% | 1.30% | 3.43% | 2.88% | 1.08% | -13.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.